AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CHS Inc.

$25.46 +$0.04 (+0.16%)
NASDAQ · 15 Sep 2026 17:13 UTC
Previous Close
$25.43
Day Range
$25.43$25.68
Year Range
$25.17$25.95
Market Cap
312.45M
AVG Volume
25.45K
Trailing/Forward PE
0/-
PEG ratio
0
Dividend Yield
7.36%
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (USD)
020B40B60B2016201720182019202020212022202320242025
CHSCL Revenue (USD) by year
PeriodRevenue (USD)
202535.46B
202439.26B
202345.59B
202247.79B
202138.45B
202028.41B
201931.9B
201832.68B
201731.93B
201630.35B
Net Income (USD)
0500M1B1.5B2B2016201720182019202020212022202320242025
CHSCL Net Income (USD) by year
PeriodNet Income (USD)
2025597.92M
20241.1B
20231.9B
20221.64B
2021553.95M
2020253.77M
2019787.71M
2018783.47M
2017127.86M
2016424.2M
Operating Income (USD)
-1B01B2B2016201720182019202020212022202320242025
CHSCL Operating Income (USD) by year
PeriodOperating Income (USD)
202576.98M
2024729.51M
20231.76B
20221.97B
2021765.11M
2020217.92M
2019660.73M
2018455.78M
2017-111.8M
2016310.2M
EBITDA (USD)
01B2B3B2016201720182019202020212022202320242025
CHSCL EBITDA (USD) by year
PeriodEBITDA (USD)
20251.42B
20241.68B
20232.61B
20222.39B
20211.16B
2020926.08M
20191.32B
20181.3B
2017596.61M
2016981.07M
Cash Flows (USD)
-1B01B2B3B2016201720182019202020212022202320242025
CHSCL Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-364.17M
2024441.37M
20232.5B
20221.57B
2021399.1M
2020654.37M
2019467.25M
2018716.66M
2017488.6M
2016570.72M
Expenses (USD)
01B2B3BSG&ACapex2016201720182019202020212022202320242025
CHSCL Expenses (USD) by year
PeriodExpenses (USD)
20252.05B
20241.97B
20231.81B
20221.37B
20211.1B
20201.13B
20191.37B
20181.03B
20171.05B
20161.32B
Cash & Debt (USD)
02B4B6BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
CHSCL Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025399.26M
20241.37B
20231.84B
2022793.96M
2021542.48M
2020140.87M
2019211.18M
2018450.62M
2017181.38M
2016279.31M
Debt ratios
00.250.50.75120182019202020212022202320242025
CHSCL Debt ratios by year
PeriodDebt ratios
20250.35
20240.2
20230.12
20220.34
20210.65
20200.83
20190.89
20180.91
Margins
0%2%4%6%8%2016201720182019202020212022202320242025
CHSCL Margins by year
PeriodMargins
20253.17%
20244.76%
20236.12%
20226.2%
20213.92%
20203.46%
20194.34%
20183.5%
20172.97%
20163.16%
Return on Capital
0%5%10%15%20%2016201720182019202020212022202320242025
CHSCL Return on Capital by year
PeriodReturn on Capital
20255.4%
202410.24%
202318.18%
202217.3%
20216.14%
20202.88%
20199.14%
20189.6%
20171.62%
20165.39%
Shares Outstanding (USD)
0200M400M600M2016201720182019202020212022202320242025
CHSCL Shares Outstanding (USD) by year
PeriodShares Outstanding (USD)
2025558.72M
2024355.93M
2023495.79M
2022111.82M
202179.38M
202096.44M
201985.54M
20188.85M
201735.27M
201623.91M
Total Assets (USD)
05B10B15B20B2016201720182019202020212022202320242025
CHSCL Total Assets (USD) by year
PeriodTotal Assets (USD)
202518.86B
202418.72B
202318.96B
202218.82B
202117.58B
202015.99B
201916.45B
201816.38B
201715.97B
201617.32B
Dividends (USD)
00.511.522017201820192020202120222023202420252026
CHSCL Dividends (USD) by year
PeriodDividends (USD)
20261.41
20251.88
20241.88
20231.88
20221.88
20211.88
20201.88
20191.88
20181.88
20171.88
Employee Count
05K10K15K2016201720182019202020212022202320242025
CHSCL Employee Count by year
PeriodEmployee Count
202510.68K
202410.66K
202310.61K
20229.17K
20219.94K
202010.49K
201910.7K
20189.89K
201711.63K
201612.16K
CHS Inc.
CHSCL
Stockpicker

Video analysis: CHSCL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CHSCL

Comprehensive Healthcare Systems Announces New Contract; Signs Amalgamated Transit Union 726 to Novus 360 TPA 3-Year Recurring Services Agreement

newsfilecorp.com · 22 Jul 2026

Comprehensive Healthcare Systems Announces New Contract; Signs Amalgamated Transit Union 726 to Novus 360 TPA 3-Year Recurring Services Agreement

Calgary, Alberta--(Newsfile Corp. - July 22, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) ("CHS" or the "Company"), an industry leader in healthcare benefits administration software and services, today announced it has signed a 3-Year Recurring Third-Party Administrator ("TPA") agreement with the Amalgamated Transit Union Local 726 Benefits Fund ("ATU 726" or the "Fund"). Under the agreement, CHS will deploy its Novus 360 solution to modernize and administer the Fund's health and welfare and related benefit programs.

Comprehensive Healthcare Systems Wins Teamsters Union Benefits Administration Contract

newsfilecorp.com · 25 Jun 2026

Comprehensive Healthcare Systems Wins Teamsters Union Benefits Administration Contract

Agreement with Teamsters Local 237 contributes to US$12.1 million (C$17 million) in three new five-year contracts signed during the past six months Calgary, Alberta--(Newsfile Corp. - June 25, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, today announced the signing of a new five-year agreement with the Teamsters Local 237 Welfare and Retirees Benefit Fund, one of the largest Teamsters-affiliated benefit organizations in the United States. The agreement further expands CHS's presence within the Taft-Hartley and multi-employer benefits market and represents the third new five-year contract signed by the Company over the past six months.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.